Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Toxicological Sciences|October 8, 2019
Central nervous system tumors in 2-year rat carcinogenicity studies: perspectives on human risk assessmentAida Sacaan, Stephane Thibault, K Nasir Khan
The Journal of Toxicological Sciences|July 3, 2020
Non-clinical combination toxicology studies: strategy, examples and future perspectiveAida Sacaan, Satoko Nonaka Hashida, Nasir K Khan
Toxicologic Pathology|October 6, 2022
Gemtuzumab Ozogamicin Treatment Results in Decreased Proliferation and Differentiation of Human Megakaryocytes but Does Not Inhibit Mature Platelet FunctionAllison Vitsky, Aida Sacaan, Wenyue Hu, et al.
Toxicology and Applied Pharmacology|October 21, 2015
Application of electroretinography (ERG) in early drug development for assessing retinal toxicity in ratsWenhu Huang, Walter Collette, Michelle Twamley, et al.
Regulatory Toxicology and Pharmacology : RTP|December 22, 2018
Pharmaceutical industry perspective on combination toxicity studies: Results from an intra-industry survey conducted by IQ DruSafe Leadership GroupJoanne Birkebak, Lorrene A Buckley, Donna Dambach, et al.
Molecular Cancer Therapeutics|November 8, 2018
Intestinal Toxicity in Rats Following Administration of CDK4/6 Inhibitors Is Independent of Primary PharmacologyStephane Thibault, Wenyue Hu, Brad Hirakawa, et al.
Journal of Medicinal Chemistry|August 12, 2009
Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomniaWilna J Moree, Bin-Feng Li, Florence Jovic, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Novel benzothiophene H1-antihistamines for the treatment of insomniaWilna J Moree, Florence Jovic, Timothy Coon, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomniaWilna J Moree, Bin-Feng Li, Said Zamani-Kord, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 25, 2023
Use of the dTAG system in vivo to degrade CDK2 and CDK5 in adult mice and explore potential safety liabilitiesPaul Yenerall, Tae Sung, Kiran Palyada, et al.
Pageof 2